MKI67 and neoplasm: Particularly elevated median Ki-67 expression (27%) was found in patients with poorly differentiated tumors and in patients with tumors showing low (1–19% immunoreactive tumor cells) or moderate (20–49% immunoreactive tumor cells) ER expression, and with a median Ki-67 value of 35% and 27%, respectively.